Targeted therapeutic agents
CA 2425508 A1 · Owner: Bednarski, Mark David · Inventors: Bednarski, Mark David; Dechene, Neal Edward; Wartchow, Charles Aaron
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Therapeutic and imaging agents which are comprised of a targeting entity a , therapeutic or treatment entity and a linking carrier are provided. The linking carrier imparts additional advantages to the therapeutic agents which , are not provided by conventional linking methods. Preferred agents of the present invention comprises a lipid construct vesicle, liposome, or , polymerized liposome. In some cases the therapeutic or treatment entity is a radioisotope, chemotherapeutic agent, prodrug toxin, or gene encoding a , protein that exhibits cell toxicity. Preferably the agent is further , comprised of a stabilizing entity that imparts additional advantages to the therapeutic or imaging …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 11, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 11, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 11, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.